Rousselle C - Search Results

1

Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity.

Rousselle C, Smirnova M, Clair P, Lefauconnier JM, Chavanieu A, Calas B, Scherrmann JM, Temsamani J. Rousselle C, et al. J Pharmacol Exp Ther. 2001 Jan;296(1):124-31. J Pharmacol Exp Ther. 2001. PMID: 11123372

2

New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy.

Rousselle C, Clair P, Lefauconnier JM, Kaczorek M, Scherrmann JM, Temsamani J. Rousselle C, et al. Mol Pharmacol. 2000 Apr;57(4):679-86. doi: 10.1124/mol.57.4.679. Mol Pharmacol. 2000. PMID: 10727512

3

Evaluation of anesthetic effects on parameters for the in situ rat brain perfusion technique.

Rousselle CH, Lefauconnier JM, Allen DD. Rousselle CH, et al. Neurosci Lett. 1998 Dec 4;257(3):139-42. doi: 10.1016/s0304-3940(98)00827-1. Neurosci Lett. 1998. PMID: 9870339

4

Study of uranium transfer across the blood-brain barrier.

Lemercier V, Millot X, Ansoborlo E, Ménétrier F, Flüry-Hérard A, Rousselle Ch, Scherrmann JM. Lemercier V, et al. Radiat Prot Dosimetry. 2003;105(1-4):243-5. doi: 10.1093/oxfordjournals.rpd.a006232. Radiat Prot Dosimetry. 2003. PMID: 14526964

5

Doxorubicin-peptide conjugates overcome multidrug resistance.

Mazel M, Clair P, Rousselle C, Vidal P, Scherrmann JM, Mathieu D, Temsamani J. Mazel M, et al. Among authors: rousselle c. Anticancer Drugs. 2001 Feb;12(2):107-16. doi: 10.1097/00001813-200102000-00003. Anticancer Drugs. 2001. PMID: 11261883

6

Screening of multidrug-resistance sensitive drugs by in situ brain perfusion in P-glycoprotein-deficient mice.

Cisternino S, Rousselle C, Dagenais C, Scherrmann JM. Cisternino S, et al. Among authors: rousselle c. Pharm Res. 2001 Feb;18(2):183-90. doi: 10.1023/a:1011080418027. Pharm Res. 2001. PMID: 11405289

7

Vector-mediated drug delivery to the brain.

Temsamani J, Rousselle C, Rees AR, Scherrmann JM. Temsamani J, et al. Among authors: rousselle c. Expert Opin Biol Ther. 2001 Sep;1(5):773-82. doi: 10.1517/14712598.1.5.773. Expert Opin Biol Ther. 2001. PMID: 11728213 Review.

8

Development of an in situ mouse brain perfusion model and its application to mdr1a P-glycoprotein-deficient mice.

Dagenais C, Rousselle C, Pollack GM, Scherrmann JM. Dagenais C, et al. Among authors: rousselle c. J Cereb Blood Flow Metab. 2000 Feb;20(2):381-6. doi: 10.1097/00004647-200002000-00020. J Cereb Blood Flow Metab. 2000. PMID: 10698076

9

Incorporation of Fast-Elimination Chemicals in Hair Is Governed by Pharmacokinetics-Implications for Exposure Assessment.

Faÿs F, Palazzi P, Zeman F, Hardy EM, Schaeffer C, Rousselle C, Beausoleil C, Appenzeller BMR. Faÿs F, et al. Among authors: rousselle c. Environ Sci Technol. 2023 May 16;57(19):7336-7345. doi: 10.1021/acs.est.2c06777. Epub 2023 May 5. Environ Sci Technol. 2023. PMID: 37146304

10

SCCS Scientific Opinion on Acid Yellow 3 (submission II) - SCCS/1631/21.

SCCS members. Electronic address: SANTE-SCCS@ec.europa.eu; Galli Rapporteur CL, Bernauer U, Bodin L, Chaudhry Q, Coenraads PJ, Dusinska M, Ezendam J, Granum B, Gaffet E, Panteri E, Rogiers V, Rousselle C, Stepnik M, Vanhaecke T, Wijnhoven S; SCCS external experts; Koutsodimou A, Uter W, von Goetz N. SCCS members. Electronic address: SANTE-SCCS@ec.europa.eu, et al. Among authors: rousselle c. Regul Toxicol Pharmacol. 2023 May;140:105364. doi: 10.1016/j.yrtph.2023.105364. Epub 2023 Mar 11. Regul Toxicol Pharmacol. 2023. PMID: 36907371 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

120 results

Search Page